Wells Fargo & Company Blue Water Vaccines Inc. Transaction History

Wells Fargo & Company

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$0.15 - $0.32 $5 - $10	34 Added 36.17%	128 $0
Q4 2023 Feb 09, 2024	SELL	$0.18 - $0.52 $27 - $80	-154 Reduced 62.1%	94 $0
Q3 2023 Nov 13, 2023	BUY	$0.51 - $1.2 $107 - $252	210 Added 552.63%	248 $0
Q2 2023 Aug 15, 2023	BUY	$0.79 - $1.29 $2 - $3	3 Added 8.57%	38 $0
Q1 2023 May 12, 2023	BUY	$1.01 - $1.56 $2 - $3	2 Added 6.06%	35 $0
Q4 2022 Feb 13, 2023	BUY	$0.92 - $1.46 $15 - $24	17 Added 106.25%	33 $0
Q2 2022 Aug 12, 2022	BUY	$2.13 - $63.0 $34 - $1,008	16 New	16 $0

2.82M

Ticker BWV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,744,900
Market Cap $2.34M
Description
Blue Water Vaccines, Inc., a biotechnology company, engages in the research and development of vaccines to prevent infectious diseases worldwide. The company's lead vaccine programs that are under preclinical development include BWV-101, an influenza vaccine; and BWV-102, a H1 pre-pandemic vaccine. It also has other pipeline under preclinical de...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.